The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer

Gastric cancer[1], also known as Stomach cancer is the third most serious gastrointestinal neoplasm worldwide, with a survival rate of about 30 –35% in the last two decades[2,3]. GC is a molecularly and histologically diverse disease that according to the locus of the tumor is categorized into two types: gastroesophageal junction adenocarcinoma (G/GEA) and gastric adenocarcinomas[4,5]. Stomach cancer is typically an asymptomatic disease o r may present with vague and imprecise symptoms in the early stages.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Tags: Review Article Source Type: research